期刊文献+

稳定过表达微小RNA-637的TPC-1细胞株建立及其对细胞增殖的影响 被引量:2

Establishment of a TPC - 1 cell line over expressing microRNA - 637 and its effect on cell proliferation
原文传递
导出
摘要 目的构建人微小RNA(miRNA,miR)-637慢病毒过表达载体,建立稳定过表达miR-637的甲状腺乳头癌TPC-1细胞株,检测其对细胞增殖的影响。方法设计针对miR-637前体的过表达基因片段,应用聚合酶链反应法(PCR)扩增目的基因片段,通过基因重组技术将目的基因片段插入GV369慢病毒载体中,进行PCR鉴定及DNA测序和比对分析,构建GV369-miR-637慢病毒表达载体。用慢病毒液感染TPC-1,建立稳定过表达miR-637的TPC-1细胞株。荧光显微镜下观察GV369-miR-637慢病毒表达载体的转染效果,反转录-聚合酶链反应(RT—PCR)检测GV369-miR-637-TPC-1、GV369-NC—TPC-1和TPC-13组细胞中miR-637的表达水平,细胞计数试剂盒(CCK-8)检测各组细胞的增殖能力。结果经限制性内切酶鉴定及DNA测序分析,成功构建GV369-miR-637慢病毒表达载体质粒。GV369-miR-637-TPC-1和GV369-NC—TPC+1细胞在荧光显微镜下均发出绿色荧光,并且转染效率高。GV369-miR-637-TPC-1组中miR-637的表达水平显著高于GV369-NC—TPC-1细胞组(45.32±3.85比2.78±1.15,P〈0.05),其增殖能力受到抑制。结论成功构建过表达miR-637的TPC-1细胞株,其抑制细胞增殖。 Objective To construct a human microRNA (miRNA, miR) -637 lentiviral expression vector and to establish a stable TPC - 1 cell line of transfected miR - 637, and to detect the effect on cell proliferation. Methods Pri -miR- 637 gene fragment amplified by polymerase chain reaction (PCR), then construction GV369 -miR -637 lentiviral expression vector by gene recombination technology. Observe GV369 - miR - 637 lentiviral expression vector transfeetion under the fluorescence microscope. The expression levels of miR - 637 were detected in GV369 - miR - 637 - TPC - 1, GV369 - TPC - 1 and TPC - 1 cell lines. The proliferation ability of the cells was detected by cell counting kit - 8 ( CCK - 8 ). Results We constructed the GV369 -miR -637 slow virus expression vector after the restriction enzyme i- dentification and DNA sequencing analysis. The expression level of miR - 637 in GV369 - miR - 637 - TPC - 1 cell group was significantly higher than that in GV369 - NC - TPC -1 cell group (45.32± 3.85 vs. 2.78 ± 1.15, P 〈 0. 05 ), and the ability of proliferation was inhibited. Conclusion We successfully constructed the miR - 637 lentiviral expression vector and the TPC - 1 - miR - 637 cell line. We successfully constructed the TPC - 1 cell line of expressing miR - 637, which inhibited cell proliferation.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2016年第7期1762-1764,共3页 Chinese Journal of Experimental Surgery
基金 河南省医学科技攻关计划项目(201402007)
关键词 微小RNA-637 慢病毒载体 细胞增殖 microRNA -637 Lentiviral expression vector Cell oroliferation
  • 相关文献

参考文献5

  • 1Lages E,Ipas H, Guttin A, et al. role in cancer [ J ]. Front Biosci 2540. MicroRNAs : molecular features and ( Landmark Ed), 2012, 17 : 2508- DOI : 10. 2741/4068.
  • 2Zhang JF, He ML, Fu WM, et al. Primate-specific microRNA-637 in- hibits tumorigenesis in hepatoeellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling [ J ]. Hepatology, 2011,54(6) :2137-2148. DOI : 10. 1002/hep. 24595.
  • 3Que T, Song Y, Liu Z, et al. Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and inva- sion via direct targeting Aktl [J]. Oncogene, 2015,34 ( 38 ) : 4952- 4963. DOI : 10. 1038/onc. 2014. 419.
  • 4Upreti D, Pathak A, Kung SK. Lentiviral vector-based therapy in head and neck cancer (Review) [ J]. Oncol Lett,2014,7 ( 1 ) :3-9. DOI : 10. 3892/ol. 2013. 1652.
  • 5田培超,刘玉峰,王怀立,罗强,陈铮,王越.靶向人神经母细胞瘤MYCN基因慢病毒载体的构建及鉴定[J].中华实验外科杂志,2014,31(8):1790-1793. 被引量:3

二级参考文献14

  • 1Bell E,Chen L,Liu T,et al.MYCN oncoprotein targets and their therapeutic potential[J].Cancer Lett,2010,293 (2):144-157.
  • 2Lu X,Pearson A,Lunec J.The MYCN oncoprotein as a drug development target[J].Cancer Lett,2003,197 (1-2):125-130.
  • 3Moreau LA,McGrady P,London WB,et al.Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study[J].Clin Cancer Res,2006,12 (19):5693-5697.
  • 4Tonelli R,Purgato S,Camerin C,et al.Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis[J].Mol Cancer Ther,2005,4(5):779-786.
  • 5Jacobs JF,van Bokhoven H,van Leeuwen FN,et al.Regulation of MYCN expression in human neuroblastoma cells[J].BMC cancer,2009,9:239-249.
  • 6Schor N F.New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence[J].Pharmacol Ther,2009,122(1):44-55.
  • 7Lu X,Pearson A,Lunec J.The MYCN oncoprotein as a drug development target[J].Cancer Lett,2003,197(1-2):125-130.
  • 8Sheppard RD,Samant SA,Rosenberg M,et al.Transgenic N-myc mouse model for indolent B cell lymphoma:tumor characterization and analysis of genetic alterations in spontaneous and retruvirally accelerated tumors[J].Oncogene,1998,17 (16):2073-2085.
  • 9Aagaard L,Rossi JJ.RNAi therapeutics:principles,prospects and challenges[J].Adv Drug Deliv Rev,2007,59(2-3):75-86.
  • 10Angart P,Vocelle D,Chan C,et al.Design of siRNA Therapeutics from the Molecular Scale[J].Pharmaceuticals (Basel),2013,6 (4):440-468.

共引文献2

同被引文献25

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部